All News

The best defense against long COVID remains COVID-19 vaccination. This short slide show highlights long COVID symptoms and CDC vaccination recommendations.

While the FDA's preliminary evaluation has not surfaced evidence of a link, the agency says it "cannot definitively rule out that a small risk may exist," and so will continue research.

Less than a quarter of persons with cirrhosis who are diagnosed with osteoporosis are started on treatment, reported researchers.

Your daily dose of the clinical news you may have missed.

A recent review analyzed the effectiveness of nonpharmacologic therapies for neuropathic pain in older adults. Results in our new slide show.

The new guideline underscores the need to overcome barriers to alcohol use disorder treatment and expand multidisciplinary care for patients with ALD.

Use of dupilumab also eliminated the need for use of a rescue inhaler in more than one-third of treated patients and the number of inhalations needed for others.

AXIOMATIC-SSP is considered the largest clinical trial of activated factor XIa inhibition added to standard antiplatelet therapy for secondary stroke prevention.

Semaglutide was associated with a lower risk of first-time and recurrent suicidal ideations in patients with obesity or overweight or T2D, according to new study.

Angela Fitch, MD, president of the Obesity Medicine Association, details what to look forward to this year in terms of obesity management.

Data from recent Austrian study suggest that sex should be considered when determining screening age for colorectal cancer, reported authors.

Your daily dose of the clinical news you may have missed.

The novel nonhormonal compound significantly reduced vasomotor symptoms and sleep disturbance while improving quality of life, according to findings.

Nearly half of patients who undergo ileal pouch-anal anastomosis develop pouchitis within 2 years post-surgery; up to 80% will develop it eventually.

Cannabis use during pregnancy, particularly continued use beyond the first trimester, was associated with SGA birth, still birth, and hypertensive disorders of pregnancy, authors reported.

After hospital discharge, persons who had COVID-19 remained at greater risk of death and myriad adverse health outcomes compared with those who had seasonal flu.

Moderna's investigational vaccine against RSV in adults showed mean efficacy of 83% against the infection and is the only mRNA technology-based RSV shot.

"It's a very rich pipeline because [agitation] is a very common and very debilitating symptom in Alzheimer's disease," Grossberg observed.